ConductScience.org, home

Paper2043927

Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.

Merritt JE and 9 others. Br J Pharmacol, 1991. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor. Papers, record 2043927. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2043927

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
PubMed
Journal
Br J Pharmacol
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2019-05-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Merritt JEJ E
2Brown AMA M
3Bund SS
4Cooper DGD G
5Egan JWJ W
6Hallam TJT J
7Heagerty AMA M
8Hickey DMD M
9Kaumann AJA J
10Keen MM

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HemodynamicsMajor topic
ImidazolesMajor topic
Receptors, ProstaglandinMajor topic
Sterol O-AcyltransferaseMajor topic
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Adenosine Diphosphate
Animals
Blood Pressure
Dose-Response Relationship, Drug
Heart Rate
Humans
In Vitro Techniques
Lung
Macaca fascicularis
Membranes
Muscle Relaxation
Muscle, Smooth, Vascular
Prostaglandin Endoperoxides, Synthetic
Receptors, Epoprostenol

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1978,455On the statistics of drug-receptor constants for partial agonists.J Pharmacol Exp Ther1976https://conductscience.org/library/papers/978455PubMed
24,827,395A highly sensitive adenylate cyclase assay.Anal Biochem1974https://conductscience.org/library/papers/4827395PubMed
37,470,763An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats.Br J Pharmacol1980https://conductscience.org/library/papers/7470763PubMed
47,044,460Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.Br J Pharmacol1982https://conductscience.org/library/papers/7044460PubMed
57,049,212Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7049212PubMed
66,130,329Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.Lancet1983https://conductscience.org/library/papers/6130329PubMed
76,136,920Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.Naunyn Schmiedebergs Arch Pharmacol1983https://conductscience.org/library/papers/6136920PubMed
86,400,136Antithrombotic assessment and clinical potential of prostacyclin analogues.Prog Med Chem1984https://conductscience.org/library/papers/6400136PubMed
93,791,868Morphological and functional characteristics of isolated resistance vessels in advanced uraemia.Clin Sci (Lond)1986https://conductscience.org/library/papers/3791868PubMed
103,545,351(5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.Br J Pharmacol1987https://conductscience.org/library/papers/3545351PubMed
112,436,701Prostacyclin analogues reduce ADP-ribosylation of the alpha-subunit of the regulatory Gs-protein and diminish adenosine (A2) responsiveness of platelets.Br J Pharmacol1987https://conductscience.org/library/papers/2436701PubMed
123,621,484Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives.Circ Res1987https://conductscience.org/library/papers/3621484PubMed
132,445,003Relaxation of isolated human pulmonary muscle preparations with prostacyclin (PGI2) and its analogs.Prostaglandins1987https://conductscience.org/library/papers/2445003PubMed
143,348,838Antiatherosclerotic and antihyperlipidemic effects of octimibate sodium in rabbits.Atherosclerosis1988https://conductscience.org/library/papers/3348838PubMed
153,328,202PGI2-receptors and molecular mechanisms in platelets and vasculature: state of the art.Pharmacol Res Commun1987https://conductscience.org/library/papers/3328202PubMed
163,385,635ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system.J Pharmacol Exp Ther1988https://conductscience.org/library/papers/3385635PubMed
172,474,350Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.Br J Pharmacol1989https://conductscience.org/library/papers/2474350PubMed
182,597,174A selective binding site for 3H-NECA that is not an adenosine A2 receptor.Biochem Pharmacol1989https://conductscience.org/library/papers/2597174PubMed
192,698,224Prostaglandin receptors in the cardiovascular system: potential selectivity from receptor subtypes or modified responsiveness.Eicosanoids1989https://conductscience.org/library/papers/2698224PubMed
201,710,526Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.Br J Pharmacol1991https://conductscience.org/library/papers/1710526PubMed

See all 21 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
19,624,532Prostanoid receptor antagonists: development strategies and therapeutic applications.Br J Pharmacol2009https://conductscience.org/library/papers/19624532PubMed
1,710,526Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.Br J Pharmacol1991https://conductscience.org/library/papers/1710526PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PTGIR5,739PubTator's text mininghttps://conductscience.org/library/genes/5739

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2043927

GET https://conductscience.org/api/papers/v1/2043927/references?page=2